These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13430709)

  • 1. Effect of N1-sulphanilyl-N2-n-butylurea on the rat thyroid.
    KUUSISTO AN; ANTILA V; TELKKA A
    Nature; 1957 Apr; 179(4564):822-3. PubMed ID: 13430709
    [No Abstract]   [Full Text] [Related]  

  • 2. Has the new antidiabetic drug, N1-sulphanilyl-N2-N-butylcarbamide goitrogenic properties? An experimental study.
    ANTILA V; KUUSISTO AN
    Acta Endocrinol (Copenh); 1956 Dec; 23(4):433-6. PubMed ID: 13394040
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of carbutamide on thyroid function in older men and women with diabetes mellitus.
    ERK V; HAAR H; MCGAVACK TH; SEEGERS W
    Diabetes; 1957; 6(1):80-2; discussion, 85-90. PubMed ID: 13397434
    [No Abstract]   [Full Text] [Related]  

  • 4. [17-hydroxy-corticosterone level in the blood during treatment with N1-sulfanilyl-N2-N-buthylcarbamide].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1957 May; 35(10):550-1. PubMed ID: 13450263
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessened insulin hypophosphatemia following N-sulfanilyl-N'-butylurea (BZ-55 or carbutamid).
    DANOWSKI TS; KUNKEL MH; MATEER FM; WEIGAND FA
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):325-7. PubMed ID: 13408248
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tolbutamide and carbutamide on thyroid function.
    BROWN J; SOLOMON DH
    Metabolism; 1956 Nov; 5(6 Part 2):813-9. PubMed ID: 13378051
    [No Abstract]   [Full Text] [Related]  

  • 7. [N1-sulfanilyl-N2-n-butylcarbamide therapy of diabetes mellitus].
    DALLE COSTE P; KLINGER R
    Minerva Med; 1956 Sep; 47(76):735-43. PubMed ID: 13387177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of ambulatory treatment of diabetes mellitus with 1-p-aminobenzenesulfonyl 3n-butylurea].
    ANDREANI G
    Minerva Med; 1956 Oct; 47(87):1435-9. PubMed ID: 13387284
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of N1-sulfanilyl-N2-n-butyl carbamid on carbohydrate metabolism and endocrine system].
    KRACHT J; KRONER B; VON HOLT C; VON HOLT L
    Schweiz Med Wochenschr; 1956 Sep; 86(39):1123-9. PubMed ID: 13380371
    [No Abstract]   [Full Text] [Related]  

  • 10. The site of action of the arylsulfonylureas in man.
    FROESCH ER; RENOLD AE; THORN GW; WINEGRAD AI
    Diabetes; 1957; 6(1):33; discussion, 43-5. PubMed ID: 13397418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Identification and measurement of N1-(butyl-carbamyl)-sulfanilamide].
    LUCATTELLI I
    Farmaco Prat; 1956 Aug; 11(8):452-7. PubMed ID: 13365652
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of substituted sulfonylureas on rat diaphragm and liver tissue.
    ASHMORE J; CAHILL GF; HASTINGS AB
    Diabetes; 1957; 6(1):26-7; discussion, 30-2. PubMed ID: 13397416
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicological studies on carbutamide.
    ANDERSON RC; HARRIS PN; WORTH HM
    Diabetes; 1957; 6(1):2-7; discussion, 19-20. PubMed ID: 13397409
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of carbutamide (Bz-55) on the metabolism of alcohol.
    FORNEY RB; HULPIEU HR
    Diabetes; 1957; 6(1):28-30; discussion, 30-2. PubMed ID: 13397417
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of effect of carbutamide on activity of rat liver glucose-6-phosphatase.
    CLARK MR; KUETHER CA; LEE HM; PETTINGA CW; SCOTT EG
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):215-7. PubMed ID: 13379466
    [No Abstract]   [Full Text] [Related]  

  • 17. The hypoglycaemic sulphonylureas.
    WALKER G
    Postgrad Med J; 1957 May; 33(379):224-7. PubMed ID: 13431547
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations in diabetic subjects treated with sulfonylurea compounds.
    BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
    Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oral hypoglycemic drug (carbutamide) on glycogen deposition by isolated rat hemidiaphragm.
    FIELD JB; WOODSON ML
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):534-6. PubMed ID: 13389512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.